Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction
NCT03105518 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-08-03
Summary
The central objective of this study will be to evaluate the relationship between estrogen levels and the pain following oocyte retrieval in women undergoing in vitro fertilization.
Conditions
- Oocyte Retrieval
- Postoperative Pain
Interventions
- DRUG
-
0.5, 1 mcg/kg
- DRUG
-
Single + Oxycodone
- DRUG
-
Oxycodone
With Acetaminophen
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Lawrence C Tsen, MD · Brigham and Women's Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-01
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- United States
Study Locations
More Related Trials
-
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
NCT02966860 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
NCT01210352 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
NCT00214942 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
NCT04218409 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
NCT00945919 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00226421 ·Status: COMPLETED ·Phase: PHASE3
-
Narcotic-Free Percutaneous Nephrolithotomy
NCT05924165 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
NCT05572190 ·Status: UNKNOWN ·Phase: PHASE1
-
Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects
NCT02576353 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
NCT03809455 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024 ·Status: COMPLETED ·Phase: NA
-
Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics
NCT03425084 ·Status: COMPLETED ·Phase: PHASE1
-
Pain, Opioids and Pro-Inflammatory Immune Responses
NCT01210066 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl
NCT03894800 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects
NCT01959204 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration
NCT03057041 ·Status: COMPLETED ·Phase: NA
-
Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes
NCT02932579 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Trial of Two Analgesics in Elderly ED Patients
NCT02703610 ·Status: WITHDRAWN ·Phase: PHASE4
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4